Cadrenal Therapeutics Ownership | Who Owns Cadrenal Therapeutics?

Cadrenal Therapeutics Ownership Summary

Cadrenal Therapeutics is owned by 3.78% institutional investors, 16.99% insiders, and 79.23% retail investors. Geode capital management is the largest institutional shareholder, holding 0.90% of CVKD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.42% of its assets in Cadrenal Therapeutics shares.

CVKD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cadrenal Therapeutics	3.78%	16.99%	79.23%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	21.63K	0.90%	$110.72K
Vanguard fiduciary trust	8.31K	0.35%	$42.55K
Tower research capital llc (trc)	393.00	0.02%	$2.01K
Advisor group	300.00	0.01%	$1.54K
Rockefeller capital management	150.00	0.01%	$768.00
Morgan stanley	100.00	0.00%	$512.00
Wells fargo & company/mn	99.00	0.00%	$507.00
Archer investment	35.00	0.00%	$179.00
Ifp advisors	30.00	0.00%	$154.00
Ubs group	3.00	0.00%	$15.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tower research capital llc (trc)	393.00	0.00%	$2.01K
Rockefeller capital management	150.00	-	$768.00
Drw securities	-	-	-
Destiny wealth partners	-	-	-
Ifp advisors	30.00	-	$154.00
Advisor group	300.00	-	$1.54K
Harbour investments	-	-	-
Archer investment	35.00	-	$179.00
Jpmorgan chase	-	-	-
Lpl financial	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	8.31K	-	8.31K
Geode capital management	21.63K	-	7.10K
Wells fargo & company/mn	99.00	-	-
Ifp advisors	30.00	-	-
Archer investment	35.00	-	-

Top Sellers

Holder	Shares	% Assets	Change
Drw securities	-	-	-25.15K
Lpl financial	-	-	-13.00K
Jpmorgan chase	-	-	-7.50K
Blackrock funding, inc. /de	-	-	-5.50K
Ubs group	3.00	-	-1.04K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	8.31K	-	8.31K	$42.55K

Sold Out

Holder	Change
Curio wealth	-1.00
Citigroup	-1.00
Harbour investments	-100.00
Clearstead advisors	-150.00
Destiny wealth partners	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	17	-5.56%	90,938	-25.15%	3	10.17%	7	-	5	150.00%
Dec 31, 2025	18	5.88%	121,486	6.39%	6	19.52%	7	-12.50%	2	-33.33%
Sep 30, 2025	17	21.43%	114,193	67.08%	5	46.02%	8	14.29%	3	-
Jun 30, 2025	14	7.69%	68,347	-1.38%	3	24.67%	7	-36.36%	3	200.00%
Mar 31, 2025	13	44.44%	69,304	366.85%	3	396.62%	11	22.22%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	33.28K	1.42%	-
Vanguard Morn Total Stk Mkt Idx Investor	33.28K	1.07%	-
Vanguard Institutional Extnd Mkt Idx Tr	16.86K	0.72%	-
Fidelity Extended Market Index	12.31K	0.40%	-
Abante Quant Value FI	6.88K	0.22%	-
iShares Micro-Cap ETF	5.23K	0.17%	-
Spartan Extended Market Index Pool F	2.30K	0.10%	-
Fidelity Series Total Market Index	2.45K	0.08%	-
NT Ext Equity Mkt Index Fund - NL	1.55K	0.07%	-
Fidelity Nasdaq Composite Index	2.04K	0.07%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 29, 2026	Pham Quang X	Chairman and CEO	Sell	$22.42K
Jun 26, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$27.54K
Jun 25, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$6.38K
Jun 22, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$32.54K
Jun 23, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$7.29K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	21
2025 Q4	-	13
2025 Q3	-	10
2025 Q1	-	-
2024 Q2	-	-

CVKD Ownership FAQ

Who Owns Cadrenal Therapeutics?

Cadrenal Therapeutics shareholders are primarily institutional investors at 3.78%, followed by 16.99% insiders and 79.23% retail investors. The average institutional ownership in Cadrenal Therapeutics's industry, Biotech Stocks , is 35.43%, which Cadrenal Therapeutics falls below.

Who owns the most shares of Cadrenal Therapeutics?

Cadrenal Therapeutics’s largest shareholders are Geode capital management (21.63K shares, 0.90%), Vanguard fiduciary trust (8.31K shares, 0.35%), and Tower research capital llc (trc) (393 shares, 0.02%). Together, they hold 1.26% of Cadrenal Therapeutics’s total shares outstanding.

Does Blackrock own Cadrenal Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cadrenal Therapeutics.

Who is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 393 Cadrenal Therapeutics shares, valued at 2.01K$.

Who is the top mutual fund holder of Cadrenal Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cadrenal Therapeutics shares, with 1.42% of its total shares outstanding invested in 33.28K Cadrenal Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools